Vericel (VCEL) Other Non-Current Liabilities (2010 - 2026)

Vericel's (VCEL) quarterly Other Non-Current Liabilities came in at $1.9 million in Q1 2026, up 1.68% year-on-year from $1.8 million in Q1 2025, and down 0.9% quarter-over-quarter from $1.9 million in Q4 2025.

Vericel (VCEL) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends

Vericel has disclosed Other Non-Current Liabilities across 17 years of filings, most recently posting $1.9 million for Q1 2026.

  • Other Non-Current Liabilities for Q1 2026 came in at $1.9 million, up 1.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 million (up 1.68% YoY), and the FY2025 annual result was $1.9 million, up 116.44% from the prior year.
  • Other Non-Current Liabilities came in at $1.9 million for Q1 2026 at Vericel, down from $1.9 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $1.9 million in Q4 2025 to a low of $19000.0 in Q1 2022.
  • The 5-year median for Other Non-Current Liabilities is $220500.0 (2024), against an average of $761142.9.
  • Across the five-year window, Other Non-Current Liabilities sank 66.67% in 2022 and soared 1100.0% in 2025, its largest moves.
  • Vericel's Other Non-Current Liabilities stood at $21000.0 in 2022, then jumped by 376.19% to $100000.0 in 2023, then soared by 776.0% to $876000.0 in 2024, then soared by 116.44% to $1.9 million in 2025, then decreased by 0.9% to $1.9 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $1.9 million (Q1 2026), $1.9 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Vericel 2.04 Bn 1.90 Bn 49.27 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.88 Mn
Dec 31, 2025 1.90 Mn
Sep 30, 2025 1.67 Mn
Jun 30, 2025 1.66 Mn
Mar 31, 2025 1.85 Mn
Dec 31, 2024 876,000.00
Sep 30, 2024 243,000.00
Jun 30, 2024 198,000.00
Mar 31, 2024 154,000.00
Dec 31, 2023 100,000.00
Sep 30, 2023 65,000.00
Jun 30, 2023 28,000.00
Jun 30, 2022 21,000.00
Mar 31, 2022 19,000.00
Dec 31, 2021 44,000.00
Sep 30, 2021 42,000.00
Jun 30, 2021 62,000.00
Mar 31, 2021 57,000.00
Dec 31, 2020 76,000.00
Sep 30, 2020 74,000.00